Neomycin sulfate

‌Neomycin Sulfate (CAS 1405-10-3)‌
✦ ‌Product Overview‌
Neomycin Sulfate (C₂₃H₄₈N₆O₁₇S, MW: 712.72) is a broad-spectrum aminoglycoside antibiotic that inhibits bacterial protein synthesis by irreversibly binding to the 30S ribosomal subunit. It is widely used in human medicine, veterinary care, and research for its antibacterial efficacy against Gram-negative and Gram-positive bacteria, including E. coli, Klebsiella, and Staphylococcus.

✦ ‌Key Advantages‌
🔹 ‌High Purity‌: ≥98% (HPLC-verified), ensuring pharmaceutical-grade reliability.
🔹 ‌Solubility‌: Highly soluble in water (≥50 mg/mL), ideal for formulations.
🔹 ‌Stability‌: Stable for 2 years under recommended storage (2–8°C, sealed).
🔹 ‌Regulatory Compliance‌: Meets ‌USP42‌ pharmacopeial standards.

✦ ‌Applications‌

• ‌Human Medicine‌: Treatment of intestinal infections, preoperative bowel preparation, and hepatic encephalopathy management.

• ‌Veterinary Use‌: Control of bacterial infections in livestock and pets.

• ‌Research‌: Study of bacterial resistance mechanisms and antimicrobial drug development.

✦ ‌Quality Assurance‌
Tested via ‌HPLC‌, ‌FTIR‌, and ‌mass spectrometry‌, with batch-specific Certificates of Analysis (COAs). Stability and solubility validated per ‌ICH guidelines‌.

✦ ‌Market Insights‌
The global antibiotics market is projected to grow at ‌4.3% CAGR (2025–2030)‌, driven by rising surgical procedures and demand for infection control in healthcare and agriculture.